316 related articles for article (PubMed ID: 36611144)
1. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D
BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
[TBL] [Abstract][Full Text] [Related]
3. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
Blyth U; Larsson M; Baird A; Waring G; Athiraman N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
[TBL] [Abstract][Full Text] [Related]
4. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
[TBL] [Abstract][Full Text] [Related]
5. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
6. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
[TBL] [Abstract][Full Text] [Related]
7. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
[TBL] [Abstract][Full Text] [Related]
8. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
9. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
10. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
McCarthy WA; Popek EJ
Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
[TBL] [Abstract][Full Text] [Related]
11. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
12. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
Sahoo D; Anuragaa S; Abhishekh B
Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
[TBL] [Abstract][Full Text] [Related]
13. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
14. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
16. Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.
Al-Riyami AZ; Al-Salmani M; Al-Hashami SN; Al-Mahrooqi S; Al-Marhoobi A; Al-Hinai S; Al-Hosni S; Panchatcharam SM; Al-Arimi ZA
Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e34-e42. PubMed ID: 29666679
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
Zwiers C; van Kamp I; Oepkes D; Lopriore E
Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805
[TBL] [Abstract][Full Text] [Related]
18. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
19. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
20. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
Patris M; Holoye A; Goldman D; De Coninck C; Colard M
Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]